| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 18 | 2013 | 467 | 1.350 |
Why?
|
| Receptors, Estrogen | 19 | 2010 | 797 | 1.240 |
Why?
|
| Selective Estrogen Receptor Modulators | 6 | 2014 | 60 | 0.800 |
Why?
|
| Tamoxifen | 9 | 2012 | 363 | 0.780 |
Why?
|
| Transcortin | 16 | 1994 | 18 | 0.750 |
Why?
|
| Estrogen Receptor beta | 5 | 2012 | 79 | 0.740 |
Why?
|
| Estradiol | 15 | 2012 | 534 | 0.630 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2012 | 198 | 0.600 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2014 | 557 | 0.590 |
Why?
|
| Transcription Factors | 13 | 2009 | 2582 | 0.570 |
Why?
|
| Estrogen Antagonists | 6 | 2012 | 103 | 0.550 |
Why?
|
| Raloxifene Hydrochloride | 2 | 2012 | 16 | 0.480 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2014 | 14 | 0.460 |
Why?
|
| Trans-Activators | 8 | 2005 | 800 | 0.450 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2014 | 44 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 1893 | 0.440 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 2 | 2012 | 37 | 0.440 |
Why?
|
| Indoles | 1 | 2014 | 179 | 0.420 |
Why?
|
| Estrogens | 6 | 2009 | 513 | 0.420 |
Why?
|
| Breast | 1 | 2014 | 214 | 0.410 |
Why?
|
| Breast Neoplasms | 5 | 2013 | 2510 | 0.360 |
Why?
|
| HeLa Cells | 14 | 2009 | 806 | 0.320 |
Why?
|
| Transcription, Genetic | 9 | 2013 | 1697 | 0.320 |
Why?
|
| RNA, Messenger | 13 | 2014 | 2816 | 0.300 |
Why?
|
| Urogenital Neoplasms | 1 | 2007 | 15 | 0.280 |
Why?
|
| Ligands | 12 | 2010 | 532 | 0.260 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 44 | 0.260 |
Why?
|
| Apoptosis | 1 | 2012 | 1789 | 0.250 |
Why?
|
| Cell Proliferation | 1 | 2012 | 2285 | 0.240 |
Why?
|
| Histone Acetyltransferases | 10 | 2006 | 314 | 0.240 |
Why?
|
| Cell Line, Tumor | 7 | 2012 | 3337 | 0.240 |
Why?
|
| Transcriptional Activation | 6 | 2009 | 484 | 0.230 |
Why?
|
| Receptors, Steroid | 6 | 2006 | 275 | 0.220 |
Why?
|
| Hydrocortisone | 5 | 1994 | 217 | 0.220 |
Why?
|
| Signal Transduction | 7 | 2014 | 4499 | 0.190 |
Why?
|
| Down-Regulation | 3 | 2014 | 699 | 0.190 |
Why?
|
| Benzazepines | 1 | 2001 | 64 | 0.190 |
Why?
|
| Transcription Factor AP-1 | 1 | 2001 | 105 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 7 | 2006 | 1062 | 0.180 |
Why?
|
| Growth Substances | 2 | 1998 | 113 | 0.170 |
Why?
|
| Nuclear Receptor Coactivator 1 | 8 | 2006 | 241 | 0.170 |
Why?
|
| DNA | 11 | 2005 | 1597 | 0.170 |
Why?
|
| Base Sequence | 15 | 2001 | 3090 | 0.160 |
Why?
|
| Nuclear Proteins | 4 | 2005 | 1265 | 0.160 |
Why?
|
| Phosphorylation | 7 | 2009 | 1615 | 0.160 |
Why?
|
| CREB-Binding Protein | 3 | 2006 | 64 | 0.150 |
Why?
|
| Anti-Allergic Agents | 1 | 1998 | 27 | 0.150 |
Why?
|
| Humans | 45 | 2014 | 124672 | 0.150 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1998 | 121 | 0.150 |
Why?
|
| Protein Binding | 6 | 2006 | 1738 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 5 | 2009 | 759 | 0.150 |
Why?
|
| Anti-Asthmatic Agents | 1 | 1998 | 112 | 0.140 |
Why?
|
| Dopamine | 3 | 1996 | 284 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 3 | 4 | 2009 | 348 | 0.130 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 1994 | 40 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 1998 | 381 | 0.120 |
Why?
|
| Steroids | 1 | 1996 | 202 | 0.120 |
Why?
|
| Molecular Sequence Data | 13 | 2000 | 3878 | 0.120 |
Why?
|
| Acetyltransferases | 2 | 2005 | 90 | 0.120 |
Why?
|
| Liver | 8 | 1993 | 1738 | 0.120 |
Why?
|
| Oncogene Proteins | 2 | 2005 | 136 | 0.120 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2014 | 24 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2006 | 2043 | 0.110 |
Why?
|
| Animals | 27 | 2009 | 34064 | 0.110 |
Why?
|
| Virus Integration | 1 | 2014 | 42 | 0.110 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2013 | 38 | 0.100 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2012 | 16 | 0.100 |
Why?
|
| Cell Nucleolus | 1 | 2012 | 55 | 0.100 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 137 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2012 | 132 | 0.100 |
Why?
|
| Histidine | 1 | 1992 | 73 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 60 | 0.100 |
Why?
|
| Cyclin D1 | 1 | 2012 | 112 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 1997 | 816 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 58 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2014 | 332 | 0.100 |
Why?
|
| MCF-7 Cells | 1 | 2012 | 222 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 337 | 0.100 |
Why?
|
| Bone Density | 1 | 2014 | 319 | 0.100 |
Why?
|
| Thyroxine | 1 | 1992 | 66 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 354 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2014 | 610 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 430 | 0.090 |
Why?
|
| Hormones | 1 | 1992 | 186 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 486 | 0.090 |
Why?
|
| Leucine | 1 | 1992 | 311 | 0.090 |
Why?
|
| Receptors, Progesterone | 7 | 2006 | 878 | 0.090 |
Why?
|
| Gene Expression Regulation | 5 | 2009 | 2521 | 0.090 |
Why?
|
| Rats | 9 | 2004 | 3676 | 0.090 |
Why?
|
| Chromatin | 1 | 2014 | 550 | 0.090 |
Why?
|
| Dexamethasone | 1 | 1992 | 276 | 0.090 |
Why?
|
| Genes | 3 | 1991 | 445 | 0.090 |
Why?
|
| Binding Sites | 7 | 2010 | 1295 | 0.090 |
Why?
|
| Female | 18 | 2014 | 66542 | 0.090 |
Why?
|
| Casein Kinase II | 1 | 2009 | 13 | 0.080 |
Why?
|
| Genes, Overlapping | 1 | 1989 | 7 | 0.080 |
Why?
|
| Androgen-Binding Protein | 1 | 1989 | 26 | 0.080 |
Why?
|
| Multienzyme Complexes | 2 | 2001 | 88 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 465 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 2 | 2001 | 114 | 0.080 |
Why?
|
| Casein Kinase Idelta | 1 | 2009 | 5 | 0.080 |
Why?
|
| Cell Nucleus | 3 | 2005 | 676 | 0.080 |
Why?
|
| Amino Acid Sequence | 11 | 2000 | 2705 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 1284 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1497 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 1251 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 802 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2010 | 306 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 1689 | 0.070 |
Why?
|
| Testis | 1 | 1989 | 407 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2014 | 835 | 0.070 |
Why?
|
| Exons | 1 | 1989 | 796 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 254 | 0.070 |
Why?
|
| Activating Transcription Factors | 1 | 2006 | 4 | 0.070 |
Why?
|
| CHO Cells | 4 | 2001 | 160 | 0.070 |
Why?
|
| Nandrolone | 1 | 2006 | 4 | 0.070 |
Why?
|
| Nuclear Matrix | 3 | 2001 | 27 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1140 | 0.060 |
Why?
|
| Cricetinae | 4 | 2001 | 413 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 1003 | 0.060 |
Why?
|
| Progestins | 2 | 2006 | 48 | 0.060 |
Why?
|
| Cloning, Molecular | 5 | 1999 | 891 | 0.060 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 79 | 0.060 |
Why?
|
| Receptors, Dopamine | 2 | 1996 | 40 | 0.060 |
Why?
|
| DNA Primers | 3 | 2001 | 657 | 0.060 |
Why?
|
| Middle Aged | 3 | 2014 | 26760 | 0.060 |
Why?
|
| Fetus | 4 | 1993 | 585 | 0.060 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2004 | 10 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2001 | 263 | 0.060 |
Why?
|
| Biological Transport | 3 | 2001 | 354 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2005 | 290 | 0.060 |
Why?
|
| Transfection | 6 | 2006 | 1061 | 0.060 |
Why?
|
| Mutation | 6 | 2010 | 5825 | 0.060 |
Why?
|
| Protein Kinase C | 2 | 2001 | 149 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 65 | 0.060 |
Why?
|
| Myelin P0 Protein | 1 | 2004 | 25 | 0.060 |
Why?
|
| DNA, Neoplasm | 1 | 2005 | 301 | 0.060 |
Why?
|
| Aging | 1 | 1991 | 1182 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2006 | 1327 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 154 | 0.050 |
Why?
|
| Gravitation | 1 | 2002 | 13 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 660 | 0.050 |
Why?
|
| Ligases | 2 | 2000 | 46 | 0.050 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2004 | 202 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 1390 | 0.050 |
Why?
|
| Calcitriol | 1 | 2002 | 80 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2002 | 69 | 0.050 |
Why?
|
| Cell Line | 3 | 2009 | 2749 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2001 | 622 | 0.050 |
Why?
|
| Inositol Phosphates | 1 | 2001 | 13 | 0.050 |
Why?
|
| Lac Operon | 1 | 2001 | 95 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2001 | 767 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 2001 | 381 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 158 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 206 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 669 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2004 | 882 | 0.040 |
Why?
|
| Norpregnenes | 2 | 2001 | 3 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2000 | 141 | 0.040 |
Why?
|
| Sexual Behavior, Animal | 2 | 1996 | 87 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1999 | 42 | 0.040 |
Why?
|
| Posture | 2 | 1996 | 154 | 0.040 |
Why?
|
| Drug Design | 1 | 1999 | 147 | 0.040 |
Why?
|
| Response Elements | 1 | 1998 | 97 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1999 | 67 | 0.040 |
Why?
|
| Antibodies, Phospho-Specific | 2 | 2009 | 3 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 1992 | 1005 | 0.040 |
Why?
|
| Neutrophils | 2 | 1990 | 381 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 118 | 0.040 |
Why?
|
| Plasmids | 1 | 1998 | 510 | 0.030 |
Why?
|
| Kinetics | 5 | 2000 | 1323 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2010 | 830 | 0.030 |
Why?
|
| Leupeptins | 3 | 2001 | 26 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2001 | 40 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 2 | 1993 | 132 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1996 | 85 | 0.030 |
Why?
|
| Glycosylation | 2 | 1992 | 120 | 0.030 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1994 | 14 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1994 | 1586 | 0.030 |
Why?
|
| Desogestrel | 1 | 1994 | 6 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1998 | 940 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1991 | 314 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 232 | 0.030 |
Why?
|
| Mice | 3 | 2007 | 17619 | 0.030 |
Why?
|
| Half-Life | 2 | 1991 | 158 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1993 | 79 | 0.030 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1993 | 28 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 319 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2005 | 201 | 0.030 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 1992 | 17 | 0.030 |
Why?
|
| Catalysis | 1 | 2013 | 126 | 0.030 |
Why?
|
| Fetal Blood | 2 | 1991 | 176 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 286 | 0.020 |
Why?
|
| Rats, Inbred BB | 1 | 1991 | 5 | 0.020 |
Why?
|
| Deoxyribonucleotides | 1 | 1991 | 10 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 289 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 330 | 0.020 |
Why?
|
| Corticosterone | 1 | 1991 | 59 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2007 | 12327 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1993 | 453 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 48 | 0.020 |
Why?
|
| Models, Biological | 1 | 1995 | 1459 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 1990 | 76 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2001 | 155 | 0.020 |
Why?
|
| Pregnancy | 6 | 1993 | 7180 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 326 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1069 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 275 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 793 | 0.020 |
Why?
|
| Leukocytes | 1 | 1990 | 205 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1989 | 81 | 0.020 |
Why?
|
| Gene Library | 1 | 1989 | 217 | 0.020 |
Why?
|
| Amino Acids | 1 | 1991 | 664 | 0.020 |
Why?
|
| Progesterone | 2 | 2006 | 623 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 393 | 0.020 |
Why?
|
| Serine | 1 | 2009 | 173 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 1989 | 150 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2004 | 3038 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 498 | 0.020 |
Why?
|
| In Vitro Techniques | 3 | 1999 | 969 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1987 | 95 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2000 | 358 | 0.020 |
Why?
|
| Trypsin | 1 | 2006 | 96 | 0.020 |
Why?
|
| Mifepristone | 1 | 2006 | 135 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2005 | 25 | 0.020 |
Why?
|
| Valine | 1 | 1985 | 113 | 0.020 |
Why?
|
| Jejunum | 1 | 1985 | 129 | 0.010 |
Why?
|
| Rabbits | 3 | 1991 | 709 | 0.010 |
Why?
|
| Lysine | 1 | 1985 | 194 | 0.010 |
Why?
|
| Molecular Weight | 3 | 1990 | 390 | 0.010 |
Why?
|
| Biglycan | 1 | 2004 | 7 | 0.010 |
Why?
|
| Sequence Alignment | 2 | 2000 | 622 | 0.010 |
Why?
|
| Collagen Type III | 1 | 2004 | 21 | 0.010 |
Why?
|
| Blotting, Western | 2 | 2001 | 1102 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 2982 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2004 | 88 | 0.010 |
Why?
|
| 20-alpha-Dihydroprogesterone | 1 | 2004 | 1 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2004 | 112 | 0.010 |
Why?
|
| In Situ Hybridization | 2 | 1996 | 470 | 0.010 |
Why?
|
| Lung | 2 | 1992 | 1490 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 172 | 0.010 |
Why?
|
| Schwann Cells | 1 | 2004 | 57 | 0.010 |
Why?
|
| Male | 6 | 2004 | 61242 | 0.010 |
Why?
|
| Norethindrone | 1 | 2001 | 6 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 2001 | 11 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 2001 | 19 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 280 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2001 | 66 | 0.010 |
Why?
|
| Tissue Distribution | 2 | 1992 | 382 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 161 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 1177 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 229 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2001 | 291 | 0.010 |
Why?
|
| Granulocytes | 2 | 1990 | 65 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2001 | 441 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6293 | 0.010 |
Why?
|
| DNA Replication | 1 | 2001 | 352 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1999 | 84 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 346 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 390 | 0.010 |
Why?
|
| Placenta | 2 | 1993 | 506 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1999 | 72 | 0.010 |
Why?
|
| Gene Expression | 2 | 1994 | 1560 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 579 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1999 | 292 | 0.010 |
Why?
|
| Arabidopsis | 1 | 1999 | 71 | 0.010 |
Why?
|
| Mammals | 1 | 1999 | 256 | 0.010 |
Why?
|
| Aged | 2 | 1992 | 19740 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 790 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1996 | 31 | 0.010 |
Why?
|
| Dopamine Antagonists | 1 | 1996 | 50 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1996 | 78 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2001 | 889 | 0.010 |
Why?
|
| Ethinyl Estradiol | 1 | 1994 | 10 | 0.010 |
Why?
|
| Biological Availability | 1 | 1994 | 136 | 0.010 |
Why?
|
| Saimiri | 1 | 1994 | 11 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 1018 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 164 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 184 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1999 | 986 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1994 | 313 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 461 | 0.010 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 1992 | 4 | 0.010 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1992 | 21 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 135 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 658 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1992 | 43 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 260 | 0.010 |
Why?
|
| Sheep | 1 | 1992 | 219 | 0.010 |
Why?
|
| Serpins | 1 | 1991 | 27 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1992 | 219 | 0.010 |
Why?
|
| Pancreatic Elastase | 1 | 1990 | 13 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1990 | 56 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1990 | 83 | 0.010 |
Why?
|
| Autoradiography | 1 | 1989 | 69 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1989 | 75 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 4256 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1993 | 1690 | 0.000 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1990 | 325 | 0.000 |
Why?
|
| Monocytes | 1 | 1990 | 351 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 101 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1987 | 114 | 0.000 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1987 | 88 | 0.000 |
Why?
|
| Serine Endopeptidases | 1 | 1987 | 177 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1990 | 779 | 0.000 |
Why?
|
| Gestational Age | 1 | 1990 | 1158 | 0.000 |
Why?
|
| Animals, Suckling | 1 | 1985 | 50 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1985 | 87 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1985 | 190 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 12471 | 0.000 |
Why?
|
| Inflammation | 1 | 1990 | 1431 | 0.000 |
Why?
|
| Adult | 2 | 1994 | 29475 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1985 | 776 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1990 | 6544 | 0.000 |
Why?
|
| Age Factors | 1 | 1985 | 2819 | 0.000 |
Why?
|